Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Pregabalin
|
| gptkbp:approves |
gptkb:2004
|
| gptkbp:category |
gptkb:C
|
| gptkbp:contraindication |
hypersensitivity to pregabalin
|
| gptkbp:dosage_form |
gptkb:beer
|
| gptkbp:form |
extended-release capsule
|
| gptkbp:has_ability |
165 mg
330 mg 82.5 mg |
| https://www.w3.org/2000/01/rdf-schema#label |
Lyrica CR
|
| gptkbp:ingredients |
pregabalin
|
| gptkbp:is_used_for |
seizures
fibromyalgia neuropathic pain |
| gptkbp:legal_issue |
prescription only
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:packaging |
blister pack
|
| gptkbp:pharmacokinetics |
bioavailability 90%
|
| gptkbp:side_effect |
dizziness
drowsiness dry mouth weight gain blurred vision |